122 related articles for article (PubMed ID: 21129814)
21. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
[TBL] [Abstract][Full Text] [Related]
22. Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells.
Siegmund D; Klose S; Zhou D; Baumann B; Röder C; Kalthoff H; Wajant H; Trauzold A
Cell Signal; 2007 Jun; 19(6):1172-84. PubMed ID: 17291719
[TBL] [Abstract][Full Text] [Related]
23. The TRAIL apoptotic pathway in cancer onset, progression and therapy.
Johnstone RW; Frew AJ; Smyth MJ
Nat Rev Cancer; 2008 Oct; 8(10):782-98. PubMed ID: 18813321
[TBL] [Abstract][Full Text] [Related]
24. Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function.
Li Y; Wang H; Wang Z; Makhija S; Buchsbaum D; LoBuglio A; Kimberly R; Zhou T
Cancer Res; 2006 Sep; 66(17):8520-8. PubMed ID: 16951164
[TBL] [Abstract][Full Text] [Related]
25. The expression of death receptor systems TRAIL-R1/-R2/-R4, CD95 and TNF-R1 and their cognate ligands in pancreatic ductal adenocarcinoma.
Gaertner F; Krüger S; Röder C; Trauzold A; Röcken C; Kalthoff H
Histol Histopathol; 2019 May; 34(5):491-501. PubMed ID: 30375637
[TBL] [Abstract][Full Text] [Related]
26. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway.
Saleem M; Kaur S; Kweon MH; Adhami VM; Afaq F; Mukhtar H
Carcinogenesis; 2005 Nov; 26(11):1956-64. PubMed ID: 15958516
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients.
Casado-Zapico S; Martín V; García-Santos G; Rodríguez-Blanco J; Sánchez-Sánchez AM; Luño E; Suárez C; García-Pedrero JM; Menendez ST; Antolín I; Rodriguez C
J Pineal Res; 2011 Apr; 50(3):345-55. PubMed ID: 21392090
[TBL] [Abstract][Full Text] [Related]
28. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513
[TBL] [Abstract][Full Text] [Related]
29. Dual role of TMS1/ASC in death receptor signaling.
Parsons MJ; Vertino PM
Oncogene; 2006 Nov; 25(52):6948-58. PubMed ID: 16715133
[TBL] [Abstract][Full Text] [Related]
30. TRAIL/TRAIL-R in hematologic malignancies.
Testa U
J Cell Biochem; 2010 May; 110(1):21-34. PubMed ID: 20336667
[TBL] [Abstract][Full Text] [Related]
31. Death receptors: targets for cancer therapy.
Mahmood Z; Shukla Y
Exp Cell Res; 2010 Apr; 316(6):887-99. PubMed ID: 20026107
[TBL] [Abstract][Full Text] [Related]
32. SKP2 confers resistance of pancreatic cancer cells towards TRAIL-induced apoptosis.
Schüler S; Diersch S; Hamacher R; Schmid RM; Saur D; Schneider G
Int J Oncol; 2011 Jan; 38(1):219-25. PubMed ID: 21109943
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
Kern MA; Haugg AM; Koch AF; Schilling T; Breuhahn K; Walczak H; Fleischer B; Trautwein C; Michalski C; Schulze-Bergkamen H; Friess H; Stremmel W; Krammer PH; Schirmacher P; Müller M
Cancer Res; 2006 Jul; 66(14):7059-66. PubMed ID: 16849551
[TBL] [Abstract][Full Text] [Related]
34. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
35. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction.
Li S; Zhou Y; Dong Y; Ip C
Anticancer Res; 2007; 27(5A):3075-82. PubMed ID: 17970047
[TBL] [Abstract][Full Text] [Related]
37. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
[TBL] [Abstract][Full Text] [Related]
38. Targeting death-inducing receptors in cancer therapy.
Takeda K; Stagg J; Yagita H; Okumura K; Smyth MJ
Oncogene; 2007 May; 26(25):3745-57. PubMed ID: 17530027
[TBL] [Abstract][Full Text] [Related]
39. Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways.
Berg D; Stühmer T; Siegmund D; Müller N; Giner T; Dittrich-Breiholz O; Kracht M; Bargou R; Wajant H
FEBS J; 2009 Dec; 276(23):6912-27. PubMed ID: 19895579
[TBL] [Abstract][Full Text] [Related]
40. Engineering death receptor ligands for cancer therapy.
Wajant H; Gerspach J; Pfizenmaier K
Cancer Lett; 2013 May; 332(2):163-74. PubMed ID: 21236560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
